ArticleFrontiers in immunology2026
Case Report: No radiographic evidence of disease for 45 months in a patient with recurrent clear cell renal cell carcinoma treated with third-line combination therapy utilizing toripalimab and axitinib.
Ye Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.